HIV/Drug Abuse Prevention Research Ethics Training Institute

 描述(申请人提供)：艾滋病毒/艾滋病大流行的演变性质、药物使用模式的动态变化、将吸毒和其他艾滋病毒危险行为定为刑事犯罪，以及在治疗和预防方面使用新技术和其他快速进步，给涉及吸毒者的艾滋病毒研究带来了不断变化的伦理挑战。美国国立卫生研究院最近呼吁所有级别的研究项目在RCR中包括面对面的指导。然而，很少有项目提供这样的培训，到目前为止，由NIDA资助(DA031608)的福特汉姆大学艾滋病毒和药物滥用预防研究培训研究所(RETI)是唯一一个为早期职业临床科学家提供经验数据的知识和能力的项目，这些数据可以加强艾滋病毒/药物滥用研究的伦理实践和政策。这项为期5年的续订将在Reti取得成功后继续并扩大。RETI的长期目标是培养新一代临床科学家，他们具有解决吸毒人群的健康和人权需求的技能，并满足全球对经验和教育资源的需求，以便为艾滋病毒/药物滥用研究、伦理实践和政策提供信息。这些目标将通过以下具体目标实现：1：增加早期职业临床科学家对艾滋病毒/药物滥用预防研究中关键伦理问题的知识和能力；2：提高职业早期临床科学家让社区参与艾滋病毒/药物滥用参与者保护的能力；3：提高职业早期临床科学家对艾滋病毒/药物滥用预防研究伦理做法/政策进行实证研究的能力；4：创建和维持一个全球信息网络，以加强艾滋病毒/药物滥用预防研究伦理知识和基于证据的伦理做法/政策；5.提供网上全球资源，以促进其他本科生和研究生培训单位教员指导和教授艾滋病毒/药物滥用预防研究伦理的能力。为了实现这些目标，该计划将：(1)从多个学科以及国内和国际环境中招募高度合格的不同种族的临床科学家；(2)更新为期两年的强化现场课程，将新的创新重点纳入艾滋病毒预防研究设计中新出现的伦理问题，纳入成瘾治疗和减少危害战略；(3)在社区参与艾滋病毒/药物滥用研究的设计和传播方面提供经验培训；(4)为受训者提供全年指导和财政支持，以设计、实施和传播对人口敏感的实证研究，为艾滋病毒/药物滥用预防研究的伦理政策和实践提供信息；(5)扩大RETI的在线公共资源，包括广泛的艾滋病毒/药物滥用研究伦理书目、伦理尺度和措施资源页面以及伦理与社会博客；以及(6)创建可下载的网络研讨会、播客、视频讲座和教育模块，供其他研究单位的教职员工和主管使用。

 DESCRIPTION (provided by applicant): The evolving nature of the HIV/AIDS pandemic, dynamic shifts in drug use patterns, criminalization of drug use and other HIV risk behaviors, along with the use of new technologies and other rapid advances in treatment and prevention create continuously changing ethical challenges for HIV research involving people who abuse drugs. NIH has recently called for research programs at all levels to include face-to-face instruction in RCR. However, few programs provide such training and to date the NIDA funded (DA031608) Fordham University HIV and Drug Abuse Prevention Research Training Institute (RETI) is the only program to provide early career clinical scientists with knowledge of and ability to generate empirical data that can enhance HIV/drug abuse research ethics practices and policies. This 5-year renewal will sustain and expand upon RETI's success. The long-term objectives of the RETI are to produce a new generation of clinical scientists with the skills to address the health and human rights needs of drug using populations and to meet the global need for empirical and educational resources to inform HIV/drug abuse research ethics practices and policies. These objectives will be met through the following specific aims: To 1: increase early career clinical scientists' knowledge of and capacity to address key ethical issues in HIV/drug abuse prevention research; 2: increase early career clinical scientists' capacity to engage communities in the construction of HIV/drug abuse participant protections; 3: increase early career clinical scientists' capacity to conduct empirical research on HIV/drug abuse prevention research ethics practices/policies; 4: create and sustain a global information network for enhancing ethical knowledge and evidence-based ethics practices/policies for HIV/drug abuse prevention research ethics; and 5: provide online global resources to facilitate the ability of faculty in other graduate and post-graduate training units to mentor and teach HIV/drug abuse prevention research ethics. To achieve these aims the program will: (1) recruit highly qualified ethnically diverse clinical scientists from multiple disciplines and national and international settings; (2) update the 2-year intensive on-site curriculum to include a new innovative focus on emerging ethical issues in HIV prevention research designs that incorporate addiction treatment and harm reduction strategies; (3) provide experiential training in community engagement in the design and dissemination of HIV/drug abuse research; (4) provide year-round mentoring and financial support for trainees to design, conduct and disseminate population-sensitive empirical studies to inform HIV/drug abuse prevention research ethics policies and practices; (5) expand RETI on-line public resources including an extensive HIV/drug abuse research ethics bibliography, Ethics Scales and Measures Resources page, and Ethics & Society blog; and (6) create downloadable webinars, podcasts, video lectures, and educational modules for use by faculty and supervisors in other research units.